Novoheart is a global stem cell biotechnology company pioneering an array of next-generation human heart tissue prototypes. Through its MyHeart Platform of bioengineered 2D and 3D heart tissue constructs including organoid chambers, Novoheart aspires to revolutionize drug discovery, helping to save time and money for developing new therapeutics by offering accurate, sensitive and reliable drug screening and disease modelling tools.

5171 California Avenue, Suite 150
Irvine, CA 92617
(949) 238-8047